Skip to main content
OpenTrials
Completed

NCT Number: NCT02840851

Brain Blood Flow: Age and Gender

Baseline cerebral blood flow through the middle cerebral artery (MCA) and cerebral vasodilator response of the MCA to inhaled carbon dioxide (CO2) will be measured in young women, young men, older women, and older men using Magnetic Resonance (MR) imaging and transcranial Doppler ultrasound (TCD). Data collection techniques will be compared.

Completed

Looking for future studies?

Notify Me

Key information

Age range

20 year–64 year

Sex eligibility

All sexes

Study type

Observational

Primary location

University of Wisconsin-Madison

Madison, Wisconsin, 53706, United States

About this study

The investigators have recently shown that cerebral blood flow responses to chemical stimuli are reduced in healthy older adults. The investigators also have preliminary data suggesting that sex differences in cerebrovascular regulation exist. The overall goal of this application is to extend on the investigators previous studies by employing advanced neuroimaging techniques to enhance the investigators understanding of neurovascular coupling in healthy aging. This study will collect clinically significant data with implications for the future risk of cognitive decline and Alzheimer's disease.

The research aims are:

  • To determine the effect of age and sex on baseline cerebral blood flow through the middle cerebral artery (MCA).
  • To determine the effect of age and sex on cerebral vasodilator responses.
  • To determine if the cerebrovascular responses measured by transcranial Doppler ultrasound (TCD) are associated with the cerebrovascular responses measured by Magnetic Resonance (MR) imaging.

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Between 20-34 or 50-69 years
  • Body mass index <34 kg/m2

Exclusion criteria

  • Current smoker
  • History or evidence of: hepatic disease, renal disease, hematological disease, peripheral vascular disease, stroke/neurovascular disease, diabetes, hypertension
  • Part of a vulnerable population (e.g. pregnant women, prisoner, individuals lacking capacity to consent, etc.)
  • Older females only: subject is not post-menopausal

Treatment and study plan

MRI

Device

Participants will undergo a MRI scan while two stepwise CO2 elevations are applied to the participant by adding fractional concentration of inspired CO2 (FICO2) at 4% and 6% each time. The end tidal CO2 (PetCO2) will be elevated and maintained constant for a few minutes at each target level. Breath-by-breath changes in respiratory rate and PetCO2 will be measured.

Other names: Magnetic Resonance Imaging

TCD

Device

Participants will undergo a TCD scan while two stepwise CO2 elevations are applied to the participant by adding fractional concentration of inspired CO2 (FICO2) at 4% and 6% each time. The end tidal CO2 (PetCO2) will be elevated and maintained constant for a few minutes at each target level. Breath-by-breath changes in respiratory and PetCO2 will be measured.

Other names: Transcranial Doppler Ultrasound

Primary outcomes

  1. Middle Cerebral Artery Blood Flow Measurement

    Time frame: 75 minutes

    Utilize the TCD and MR imaging to measure middle cerebral artery blood flow in the brain while the participant is at rest.

  2. Middle Cerebral Artery Blood Flow Reactivity to Hypercapnia

    Time frame: 75 minutes

    Utilize the TCD and MR imaging to measure middle cerebral artery blood flow reactivity to hypercapnic gas.

Sponsors and collaborators

Lead sponsor

University of Wisconsin, Madison

Other

Registry information

Official study title

Brain Blood Flow Response to Hypercapnia in Healthy Adults: The Effect of Age and Sex

Important dates

Study start
2016
Primary completion
2018
Study completion
2018
First posted
Jul 21, 2016
Registry last updated
Dec 9, 2019

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.